FDA approves Dapagliflozin (SGLT2 inhibitor) in Systolic Heart Failure
Dr RR Baliga's "Got Knowledge Doc" Podkast · MasterMedFacts.com
May 7, 20209m 30s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
FDA approves Dapagliflozin (SGLT2 inhibitor) in Systolic Heart Failure | Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians | Not Medial Advice or Opinion